Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Champions Oncology (CSBR) Revenue (2016 - 2025)

Historic Revenue for Champions Oncology (CSBR) over the last 16 years, with Q4 2025 value amounting to $15.0 million.

  • Champions Oncology's Revenue rose 1146.12% to $15.0 million in Q4 2025 from the same period last year, while for Oct 2025 it was $58.4 million, marking a year-over-year increase of 905.9%. This contributed to the annual value of $56.9 million for FY2025, which is 1353.6% up from last year.
  • According to the latest figures from Q4 2025, Champions Oncology's Revenue is $15.0 million, which was up 1146.12% from $14.0 million recorded in Q3 2025.
  • In the past 5 years, Champions Oncology's Revenue ranged from a high of $17.0 million in Q1 2025 and a low of $10.6 million during Q2 2021
  • Its 5-year average for Revenue is $13.0 million, with a median of $13.0 million in 2022.
  • As far as peak fluctuations go, Champions Oncology's Revenue crashed by 1896.23% in 2023, and later soared by 4176.72% in 2025.
  • Over the past 5 years, Champions Oncology's Revenue (Quarter) stood at $11.8 million in 2021, then rose by 21.17% to $14.3 million in 2022, then decreased by 18.96% to $11.6 million in 2023, then grew by 16.56% to $13.5 million in 2024, then rose by 11.46% to $15.0 million in 2025.
  • Its Revenue was $15.0 million in Q4 2025, compared to $14.0 million in Q3 2025 and $12.4 million in Q2 2025.